Catalyst Wire Dossier Catalyst Wire Dossier

5-aminolevulinic acid (5-ALA)

5-aminolevulinic acid
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for 5-aminolevulinic acid (5-ALA), covering 2010-10-22 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid(5-ALA) [Phase 3]

See pricing